| 产品名称 | Peptides EP07865_1 | HA-1 137-145 His139 (HLA-A*02:01) |
|---|---|
| 目录号 | EP07865_1 |
| 别名 | HA-1 137-145 His139 (HLA-A*02:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP07865_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP07865_1 | HA-1 137-145 His139 (HLA-A*02:01)
品名：HA-1 137-145 His139 (HLA-A*02:01)
货号：EP07865_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
Antigen Peptide HA-1 137-145 His139 (HLA-A*02:01) VLHDDLLEA for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. VLHDDLLEA is a linear peptidic epitope (epitope ID136896) studied as part of Minor histocompatibility protein HA-1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays.
| Protein | Rho GTPase-activating protein |
| Species | Human |
| Application | Flow Cytometry |
| Indication | Cancer |
